EMT(SH:601208)2023-04-28 16:00Financial Performance - Total comprehensive income for Q1 2023 was CNY 71,089,639.71, a decrease from CNY 102,333,430.67 in Q1 2022, representing a decline of approximately 30.5%[5] - Basic and diluted earnings per share for Q1 2023 were both CNY 0.08, down from CNY 0.11 in Q1 2022, reflecting a decrease of 27.3%[5] - Total operating revenue for Q1 2023 was ¥858,320,668.73, a decrease of 5.1% compared to ¥904,402,611.18 in Q1 2022[19] - Net profit attributable to shareholders of the parent company for Q1 2023 was ¥70,660,358.04, a decrease of 30.6% from ¥101,756,880.47 in Q1 2022[22] - The net profit attributable to shareholders of the listed company is RMB 70,660,358.04, down 30.56% year-on-year[34] Cash Flow - Cash inflow from operating activities totaled CNY 381,659,839.74 in Q1 2023, compared to CNY 474,003,988.09 in Q1 2022, indicating a decline of about 19.5%[7] - Cash outflow from operating activities increased to CNY 649,271,758.50 in Q1 2023, up from CNY 581,967,175.96 in Q1 2022, marking an increase of approximately 11.6%[9] - Net cash flow from operating activities was negative CNY 267,611,918.76 in Q1 2023, worsening from negative CNY 107,963,187.87 in Q1 2022[9] - The net cash flow from operating activities is RMB -267,611,918.76, a decline of 147.87% compared to the previous year[34] Investment Activities - Cash inflow from investment activities was CNY 902,439,012.69 in Q1 2023, significantly higher than CNY 337,824,594.41 in Q1 2022, representing an increase of about 167.5%[9] - Cash outflow from investment activities rose to CNY 967,559,559.92 in Q1 2023, compared to CNY 514,907,938.38 in Q1 2022, an increase of approximately 88.0%[9] - Investment income increased by 180.53% due to higher returns from bank wealth management and investments in joint ventures[28] Assets and Liabilities - The total assets of the company as of Q1 2023 amounted to CNY 9,510,369,849.17, an increase from CNY 9,054,654,967.73 in Q1 2022, representing a growth of approximately 5.0%[12] - The company's total liabilities increased to ¥5,051,814,698.66 in Q1 2023, compared to ¥4,687,282,816.23 in Q1 2022, marking an increase of 7.8%[17] - The total non-current liabilities rose significantly to ¥2,254,992,714.00 in Q1 2023, compared to ¥1,969,242,718.36 in Q1 2022, an increase of 14.5%[17] Equity - The total equity attributable to shareholders of the parent company rose to ¥4,302,140,203.76 in Q1 2023, up from ¥4,211,121,585.02 in Q1 2022, representing a growth of 2.2%[17] - The total equity attributable to shareholders of the listed company is RMB 4,302,140,203.76, an increase of 2.16% from the previous year[34] Cash and Cash Equivalents - The company's cash and cash equivalents at the end of Q1 2023 were CNY 1,437,354,267.04, up from CNY 562,282,135.30 at the end of Q1 2022, indicating an increase of about 155.7%[9] - As of March 31, 2023, the company's cash and cash equivalents amounted to RMB 1,465,942,770.20, an increase from RMB 1,427,729,848.41 as of December 31, 2022, reflecting a growth of approximately 2.0%[47] - The company's cash and cash equivalents decreased to ¥194,428,908.26 from ¥235,676,396.35 year-over-year, a decline of 17.5%[17] Research and Development - Research and development expenses for Q1 2023 were ¥53,572,120.70, an increase of 27.8% compared to ¥41,944,573.15 in Q1 2022[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period is 24,576[46]